|Bid||186.20 x 0|
|Ask||186.50 x 0|
|Day's Range||186.20 - 192.00|
|52 Week Range||105.00 - 220.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cannassure Completes Their Medical Cannabis Analytical Method Development and Validation in Accordance With the Israeli Medical Cannabis Agency (IMCA) Requirements
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the new agritech wave of innovation in the cannabis sector. Since the passage of the Farm Bill late last year, the development and distribution of CBD and hemp products nationwide has greatly expanded, creating a need for new agricultural technologies. EnviroTechnologies International, Inc. (ETII), a company that develops and markets green, natural and organic products, recently confirmed that it is preparing to introduce its patent pending water treatment technology to licensed cannabis growers in the northwest.
ASHDOD, Israel, Jan. 30, 2019 /PRNewswire/ -- Cannassure Therapeutics (CSURE.TA) announces its collaboration with Cannika Holdings, an agritech incubator specializing in cannabis innovation. Cannika will operate out of the Cannassure campus, utilizing their many facilities that are designed to meet the highest regulatory standards.
ASHDOD, Israel , Jan. 15, 2019 /CNW/ - Cannassure Therapeutics Ltd. (CSURE.TA), designed to grow, extract and develop medical cannabis, announces its renewed trading on the TASE after completing its reverse merger and move from the TASE maintenance list. This was made possible by a private investment of 17.5 million NIS , in cash, from Solbar Food Technologies, the company's controlling shareholder. Cannassure's shareholder equity is estimated at 25 million NIS , mainly in cash, and is designated towards advancing infrastructure and new product development.